Hyperion Defi (HYPD) Depreciation & Amortization (CF) (2017 - 2024)
Hyperion Defi (HYPD) posted quarterly Depreciation & Amortization (CF) of $297844.0 for Q4 2024, up 7.32% year-over-year from $277524.0 in Q1 2024, and up 3.6% quarter-over-quarter from $287481.0 in Q3 2024.
Hyperion Defi (HYPD) Depreciation & Amortization (CF) (2017 - 2024) Analysis & Trends
Hyperion Defi (HYPD) has reported Depreciation & Amortization (CF) for 8 consecutive years, with $297844.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Depreciation & Amortization (CF) rose 7.32% year-over-year to $297844.0; the TTM figure through Sep 2025 stood at $297844.0 (down 73.12% YoY), while the FY2024 annual figure was $1.1 million, up 44.08% from the prior year.
- Depreciation & Amortization (CF) advanced to $297844.0 in Q4 2024 per HYPD's latest filing, from $287481.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $318417.0 in Q3 2023 and bottomed at $21114.0 in Q2 2020.
- Historically, Depreciation & Amortization (CF) has averaged $126803.2 across 5 years, with a median of $74375.0 in 2021.
- Annual changes were most pronounced in 2020 — Depreciation & Amortization (CF) jumped 1005.72% — and 2023, when it decreased 16.32%.
- Hyperion Defi's Depreciation & Amortization (CF) stood at $23787.0 in 2020, then surged by 208.23% to $73318.0 in 2021, then rose by 7.11% to $78532.0 in 2022, then surged by 253.39% to $277524.0 in 2023, then climbed by 7.32% to $297844.0 in 2024.
- Business Quant data shows HYPD's Depreciation & Amortization (CF) at $297844.0 in Q4 2024, $287481.0 in Q3 2024, and $295396.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 297,844.00 |
| Dec 31, 2024 | 297,844.00 |
| Sep 30, 2024 | 287,481.00 |
| Sep 30, 2024 | 287,481.00 |
| Jun 30, 2024 | 295,396.00 |
| Jun 30, 2024 | 295,396.00 |
| Mar 31, 2024 | 247,728.00 |
| Mar 31, 2024 | 247,728.00 |
| Dec 31, 2023 | 277,524.00 |
| Dec 31, 2023 | 277,524.00 |
| Sep 30, 2023 | 318,417.00 |
| Sep 30, 2023 | 318,417.00 |
| Jun 30, 2023 | 124,148.00 |
| Jun 30, 2023 | 124,148.00 |
| Mar 31, 2023 | 63,119.00 |
| Mar 31, 2023 | 63,119.00 |
| Dec 31, 2022 | 78,532.00 |
| Dec 31, 2022 | 78,532.00 |
| Sep 30, 2022 | 82,997.00 |
| Sep 30, 2022 | 82,997.00 |